Document is current
Any future updates will be listed below
-
Authors
Veuskens, Bert R. J.
Brouwer, Mieke C.
van Mierlo, Gerard
Geissler, Judy
van Leeuwen, Karin
Derlagen, Maaike
Keijzer, Nadia C. H.
Hoogenboezem, Mark
Kuijpers, Taco W.
Pouw, Richard B.
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme (899163, 899163, 899163)
Sanquin Research Fund (SRF-YIA-23-06)
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 11 March 2025
First Online: 28 March 2025
Declarations
:
: MCB, TWK and RBP are co-inventors of patents and patents applications describing potentiating anti-FH antibodies and uses thereof. All other authors declare no conflict of interest.
: After consultation with the ethical board of Sanquin Research, Amsterdam, The Netherlands, a system was established for obtaining blood samples for scientific research (no approval number available). This volunteer system is organized according to Dutch regulations and according to the Declaration of Helsinki. This volunteer system certifies, among others, that: Blood samples used for scientific studies by researchers of the Sanquin Research department were drawn from healthy, anonymized volunteers with written informed consent; No personal characteristics of the volunteers are registered; The volunteers nor those taking the samples know for what project specific samples are used; Allowed annual sample volume and frequency of donation were established after consultation with Sanquin Medical Secretary. Standard operating procedures are available upon request.
